Quick Takeaways
- Decheng Capital Global Life Sciences Fund IV, L.P. filed SCHEDULE 13G/A for CG ONCOLOGY, INC. Common stock, $0.0001 par value per share (CGON).
- Disclosed ownership: 8.4%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"Decheng Capital Global Life Sciences Fund IV, L.P. disclosed 8.4% ownership in CG ONCOLOGY, INC. Common stock, $0.0001 par value per share (CGON) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 7% | 5,315,954 | 0 | 5,315,954 | /s/ Xiangmin Cui | By Decheng Capital Management IV (Cayman), LLC, its General Partner, By Xiangmin Cui, Manager | |
| Decheng Capital Management IV (Cayman), LLC | 7% | 5,315,954 | 0 | 5,315,954 | /s/ Xiangmin Cui | By Xiangmin Cui, Manager | |
| Decheng Capital Global Healthcare Fund (Master), LP | 1.4% | 1,055,715 | 0 | 1,055,715 | /s/ Xiangmin Cui | By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager | |
| Decheng Capital Global Healthcare GP, LLC | 1.4% | 1,055,715 | 0 | 1,055,715 | /s/ Xiangmin Cui | By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager | |
| Xiangmin Cui | 8.4% | 6,371,669 | 0 | 6,371,669 | /s/ Xiangmin Cui | Xiangmin Cui |